Drugs will be tested simultaneously, which it's hoped will speed up the process of finding new treatments for this common ...

“For too long, Alzheimer’s research has moved at the pace of one drug, one trial, one answer.” ...

A new report argues that more flexible eligibility criteria could widen pharma’s clinical trial pool without sacrificing ...

Andy Burnham, whose father Roy died with the disease last month, said he was proud to support the trial in the hope people ...

A rare examination of an Alzheimer’s patient’s brain revealed that regions cleared of amyloid plaques had remarkably little of the harmful tau buildup associated with memory loss, while neighboring ...

Accounts raise tantalizing questions about what happens inside a brain afflicted by dementia and whether cognitive abilities could possibly be restored.

The AD-SMART trial tests repurposed drugs like metformin and atomoxetine in a hopeful, faster approach to Alzheimer’s care.

Alzheimer's disease may not be a single, uniform condition, but a complex disorder shaped by different combinations of ...

Nuclear medicine is playing an increasingly important role in the diagnosis and treatment of Alzheimer's disease, helping ...

David Cameron is calling for a dedicated dementia drug fund to help thousands of Alzheimer's patients get access to ...

Programs that support caregivers of patients with dementia could bring substantial benefits at a fraction of the price of an Alzheimer’s drug. Disease-slowing Alzheimer’s drugs entered the market in ...

A large pharmacovigilance analysis of FDA adverse event reports found no overall dementia risk signal for endocrine and ...